Global Human Milk Oligosaccharides Market by Application (Infant Formula, Functional Food & Beverages, Food Supplements) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global human milk oligosaccharides sales were estimated at USD 19.3 Million in 2019. They are expected to grow at a 23.0% CAGR during the forecast period. The market is expected to grow due to growing concerns about gut health and increased consumption of nutritional supplements. Human Milk Oligosaccharides, or HMOs, act as probiotics in our bodies and maintain gut health. They encourage bacterial growth in the gut, particularly bifidobacteria. This helps to improve metabolic activity. They can be used in a variety of food products including infant formulas and pharmaceutical and medical food.

The HMO market will be constrained by a lack of technology, high R&D costs, and strict government regulations. The largest market for this product is infant formula. It promotes health and prevents diseases in infants. These products also play an important role in brain development and memory enhancement in people.

Human milk oligosaccharides serve three primary functions: the prevention of infection, sialic acid supply for brain development and prebiotic effects. Bovine milk formulas have a lower concentration of oligosaccharides than those made from human milk.

Many enzymes and chemicals required to make human milk oligosaccharides can be very costly and are not readily available. This is likely to limit market growth. HMOs are most commonly used in infant formula, followed closely by functional food and beverages. Another factor that drives the market for human milk oligosaccharides is the demand for high-nutrition foods for both children and adults.

The essential components of breastmilk are human milk oligosaccharides. They are essential components of breast milk and promote good health. They are beneficial for infant brain, digestive, and immune development. HMO supplements have been shown to increase beneficial bacteria in the gut for adults. Breast milk is not always available to all infants. This leads to synthetic production of HMOs using various production methods.

Human milk oligosaccharides are incorporated in functional foods and beverages to promote the growth of good bacteria. It also eliminates harmful bacteria such as salmonella, listeria and campylobacter. The market for functional foods is dominated by dairy products. Functional food and beverages that have prebiotic properties are in high demand.

Prebiotic effects and neurological stimulation are two of the many benefits that human milk oligosaccharides provide to humans. These properties will drive demand for HMO in functional foods and beverages. Inbiose NV, Glycom A/S, ZuChem, Inc., and Glycosyn LLC are all working to develop human milk oligosaccharides that can be used in functional food and beverages.

Application Insights

In 2019, infant formula was the most popular application, accounting for almost 81% of global revenue share. HMOs are increasingly being used in the design of infant formulas due to their beneficial properties, including prevention from infection, prebiotic effects and memory enhancement.

Functional food and beverages accounted for more than 9.1% of market revenue in 2019. HMO offers many health benefits, so functional food and beverages will continue to be a major market segment. This is expected to drive product demand.

HMOs are used in dietary supplements for their benefits, including immune support, protection from bacterial and virus infections, digestive comfort, brain function support, and digestive support. The major drivers of the food supplement industry are rising healthcare costs, changing lifestyles, increasing geriatric populations, and increased disposable income.

Regional Insights

In 2019, North America accounted for the largest share of the global market for human milk Oligosaccharides. In the future, the region will see significant market growth due to the presence of many prominent baby formula and baby food producers as well as technological advances.

The market growth in Europe is expected to be boosted by the growing demand for infant food, the large number of HMO producers and regulatory approvals of HMO in infant formula. Due to cuts in public funding and lack of information about the health benefits breast milk has, the U.K. has the lowest rate of breastfeeding. This indicates that there is a lot of potential for product penetration.

Asia Pacific HMO market will be driven by factors like rising population, death rate, disposable income, consumer awareness about hygiene, and health and hygiene. There is a growing demand for functional foods and beverages due to rising concerns about gut diseases, diabetes, high blood pressure, high blood sugar, and rickets, among other chronic diseases. This will drive the demand for human milk Oligosaccharides in Asia Pacific. The demand for baby food and dietary supplements is expected to grow in India and China over the forecast period.

Market Share in Human Milk Oligosaccharides

Many manufacturers invest heavily in R&D to develop low-cost technologies that can produce HMOs on large scales. The market for HMOs at the moment is very niche. There are many applications for HMOs, including functional foods, beverages, and food supplements. A large portion of HMOs currently manufactured goes to infant formula. Manufacturers are using partnerships, agreements and capacity expansions to meet the increasing demand.

Innovating their product offerings has been a top priority for prominent market players over the years. Jennewein Biotechnologie GmbH, which is a German-based manufacturer of functional sugars, partnered in February 2019 with Yili.Com Inc. to conduct research on infant microbiome, human milk oligosaccharides, and Yili.Com Inc. This strategy was designed to create innovative HMO-based infant formula, and was targeted at Chinese customers. Such developments/strategies are likely to surface over the forecast period, given the rising competition in the market.

Inbiose NV, Elicityl S.A., Jennewein Biotechnologie GmbH, Glycom A/S and Medolac Laboratories are the major players in the HMO market. Regional entrants have been discouraged by the complex technology required to manufacture HMOs.

The Report Covers Certain Segments

This report forecasts volume and revenue growth at the global, regional and country level. It also provides analysis of industry trends for each sub-segment from 2016-2027. Grand View Research has divided the global market for human milk oligosaccharides on the basis of region and application.

• Application Outlook (Volume and Tons; Revenue USD Thousand, 2016-2027)

  • Infant Formula

  • Functional Food & Beverages

  • Supplements for Food

  • Other

• Regional Outlook (Volume and Tons; Revenue USD Thousand, 2016-2027)

  • North America

    • The U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • The U.K.

    • France

  • Asia Pacific

    • China

    • India

    • Japan

  • Central & South America

    • Brazil

  • Middle East & Africa

    • UAE

These are the most frequently asked questions about this report

b. Global human milk oligosaccharides (HMO) market was valued at USD 19.36 Million in 2019. It is projected to grow to USD 22.82 millions in 2020.

b. Global human milk oligosaccharides markets are expected to increase at a compound annual rate of 23% between 2019 and 2027, reaching USD 101.51 millions by 2027.

b. With a market share of 79.6%, North America dominated human milk oligosaccharides in 2019, This can be attributed to the prominence of many prominent baby formula and baby food producers, as well as technological advances.

b. Inbiose NV, Elicityl S.A., Jennewein Biotechnologie GmbH, Glycom A/S and Medolac Laboratories are some of the key players in the human milk oligosaccharides marketplace. ZuChem Inc. is another.

b. The market growth is being driven by two key factors: growing concerns about gut health among consumers and an increase in the consumption of dietary supplements.

Up Market Research published a new report titled “Human Milk Oligosaccharides Market research report which is segmented by Application (Infant Formula, Functional Food & Beverages, Food Supplements), By Players/Companies Inbiose NV; Elicityl SA; Jennewein Biotechnologie GmbH; Glycom A/S; Medolac Laboratories; ZuChem Inc; and Glycosyn LLC”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Human Milk Oligosaccharides Market Report Segments:

The market is segmented by Application (Infant Formula, Functional Food & Beverages, Food Supplements).

Human Milk Oligosaccharides Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Human Milk Oligosaccharides Market

Overview of the regional outlook of the Human Milk Oligosaccharides Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Human Milk Oligosaccharides Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Human Milk Oligosaccharides Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Infant Formula

                2. Functional Food & Beverages

                3. Food Supplements

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Human Milk Oligosaccharides Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Human Milk Oligosaccharides Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.